SCHEMBL15614972

SCHEMBL15614972

CC1(C)OC(C)(C)c2cc(B3OC(C)(C)C(C)(C)O3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 13/20 0.46
▸ LIPG Q9Y5X9 13/20 0.46
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA3 P07451 1/20 0.39
▸ CA4 P22748 1/20 0.39
▸ CA6 P23280 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ CA5B Q9Y2D0 1/20 0.39
▸ F11 P03951 1/20 0.38
▸ ESR2 Q92731 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ BACE1 P56817 1/20 0.34
▸ P4HB P07237 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15614857 0.82 LPL (0.38) LPLLIPGCA1CA2CA9
SCHEMBL17486107 0.79 DGAT1 (0.52) LPLLIPGIRAK4
SCHEMBL15614863 0.79 LPL (0.46) LPLLIPGCA1CA2CA9
SCHEMBL15614871 0.78 LPL (0.46) LPLLIPGCA1CA2CA9
SCHEMBL15614852 0.77 LPL (0.42) LPLLIPGCA1CA2CA9
SCHEMBL20627954 0.77 LPL (0.45) LPLLIPGCA1CA2CA9
SCHEMBL2014065 0.76 LPL (0.44) LPLLIPGCA1CA2CA9
SCHEMBL16905126 0.76 LPL (0.44) LPLLIPGCA1CA2CA9
SCHEMBL2012175 0.76 LPL (0.44) LPLLIPGCA1CA2CA9
SCHEMBL15614983 0.76 LIPG (0.46) LPLLIPGCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 — — US disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 — — US disclosed
US-11005050-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-05-11 — — US disclosed
EP-3424936-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2021-04-07 — — EP disclosed
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 — — EP disclosed
EP-3424936-A1 METAL COMPLEXES Merck Patent GmbH (DE) 2019-01-09 — — EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
EP-3094638-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-11-08 — — EP disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 — — US disclosed
US-20170170413-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-06-15 — — US disclosed
US-20170170413-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-06-15 — — US disclosed
US-20160365520-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed
US-20160365520-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 — — WO disclosed
WO-2015117718-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2015-08-13 — — WO disclosed
WO-2015104045-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2015-07-16 — — WO disclosed
US-20150171348-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-06-18 — — US disclosed
US-20150171348-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-06-18 — — US disclosed
WO-2014023377-A2 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150171348-A1 Metal Complexes SOD1, AP1M1, AP3M1 LPL 3163/4885LIPG 3210/4885CA1 2357/4885
US-11005050-B2 Metal complexes SOD1, AP1M1, AP3M1 LPL 3163/4885LIPG 3210/4885CA1 2357/4885
US-20160365520-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 LPL 3163/4885LIPG 3210/4885CA1 2357/4885
US-20170170413-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 LPL 3163/4885LIPG 3210/4885CA1 2357/4885
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 LPL 3163/4885LIPG 3210/4885CA1 2357/4885
US-11917901-B2 Metal complexes MCOLN2, MCOLN1, AP1M1 LPL 2338/4885LIPG 2895/4885CA1 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback